A Prospective Cohort Study Evaluating the Efficacy and Safety of Guselkumab (GUS) With JAK Inhibitors in Patients With Difficult-To-Treat Inflammatory Bowel Disease (IBD)
Clinical trial NCT07487311 · RECRUITING
Trial details
- NCT number
- NCT07487311
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-01-07
- Primary completion
- 2027-12-31
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.